59032-40-5|Disulergine|N,N-Dimethyl-N'-((8 alpha)-6-methylergolin-8-yl)sulfamide|-范德生物科技公司

Disulergine

NMR下载 COA and HPLC MSDS下载
names：
N,N-Dimethyl-N'-((8 alpha)-6-methylergolin-8-yl)sulfamide
CAS号：
59032-40-5
MDL Number：
MF(分子式)： C17H24N4O2S MW(分子量)： 348.465
EINECS: Reaxys Number:
Pubchem ID: Brand:BIOFOUNT

货品编码	规格	纯度	价格 (¥)	现价(¥)	特价(¥)	库存描述	数量	总计 (¥)

大包装询价提供各种包装，敬请垂询
收藏商品商品点评加入购物车立即购买

快速询价

收起

你想询价的产品

*产品名称：

CAS号：

产品编号：

需求描述：

请准确填写您的联系方式，以便为您提供最好的服务。

*公司名称：

*电子邮箱：

联系人：

*电话：

*验证码：

询价

中文别名	Disulergine
英文别名	Disulergine; CH 29717; CH 29-717; CM 29717
CAS号	59032-40-5
Inchi	InChI=1S/C17H24N4O2S/c1-20(2)24(22,23)19-12-8-14-13-5-4-6-15-17(13)11(9-18-15)7-16(14)21(3)10-12/h4-6,9,12,14,16,18-19H,7-8,10H2,1-3H3/t12-,14+,16+/m0/s1
InchiKey	VUEGYUOUAAVYAS-JGGQBBKZSA-N
分子式 Formula	C17H24N4O2S
分子量 Molecular Weight	348.465
溶解度Solubility
性状	Solid powder
储藏条件 Storage conditions	Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).

产品说明	Disulergine(CAS:59032-40-5):仅限应用于工业或者科学研究过程中非医疗目的，不应用于人类或动物的临床诊断以及治过程疗，该产品非药用，非食用。
Introduction	Disulergine is a dopamine receptor agonist and prolactin release-inhibiting 8 alpha-amino-ergoline.
Application1
Application2
Application3

警示图
危险性	Warning
危险性警示
安全声明
安全防护
备注

[1]Spada A, Bassetti M, Reza-Elahi F, Arosio M, Gil-Del-Alamo P, Vallar L. Differential transduction of dopamine signal in different subtypes of human growth hormone-secreting adenomas. J Clin Endocrinol Metab. 1994 Feb;78(2):411-7. PubMed PMID: 7906281.

[2]Spada A, Sartorio A, Bassetti M, Pezzo G, Giannattasio G. In vitro effect of dopamine on growth hormone (GH) release from human GH-secreting pituitary adenomas. J Clin Endocrinol Metab. 1982 Oct;55(4):734-40. PubMed PMID: 7107817.

[3] Markó M. Dopamine agonistic potency of two novel prolactin release-inhibiting ergolines. Eur J Pharmacol. 1984 Jun 1;101(3-4):263-6. PubMed PMID: 6468500.

[4] Flückiger E, Briner U, Bürki HR, Marbach P, Wagner HR, Doepfner W. Two novel prolactin release-inhibiting 8 alpha-amino-ergolines. Experientia. 1979 Dec 15;35(12):1677-8. PubMed PMID: 520501.

[5] Spada A, Bassetti M, Martino E, Giannattasio G, Beck-Peccoz P, Sartorio A, Vallar L, Baschieri L, Pinchera A, Faglia G. In vitro studies on TSH secretion and adenylate cyclase activity in a human TSH-secreting pituitary adenoma. Effects of somatostatin and dopamine. J Endocrinol Invest. 1985 Jun;8(3):193-8. PubMed PMID: 2863299.

6: Nielsen EB, Randrup K, Andersen PH. Amphetamine discrimination: effects of dopamine receptor agonists. Eur J Pharmacol. 1989 Jan 31;160(2):253-62. PubMed PMID: 2569406.7: Grossman A, Yeo T, Delitala G, Hathway NR, Besser GM. Two new dopamine agonists that are long acting in vivo but short acting in vitro. Clin Endocrinol (Oxf). 1980 Dec;13(6):595-9. PubMed PMID: 7226572.8: Prysor-Jones RA, Jenkins JS. Effect of bromocriptine, ergotamine and other ergot alkaloids on the hormone secretion and growth of a rat pituitary tumour. J Endocrinol. 1980 Jul;86(1):147-53. PubMed PMID: 7430884.

对不起，暂无产品评价！

MSDS

SDS 1.0 中文

展开

SDS 1.0 英文

展开